Zhen Teng Liu
Chief Executive Officer bij SHANDONG LUOXIN PHARMACY GROUP CO LTD
Vermogen: 3 M $ op 31-03-2024
Profiel
Zhen Teng Liu is currently the Chairman & General Manager at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
and Luoxin Pharmaceuticals Group Stock Co., Ltd.
He started his current positions in 2013 and 2020 respectively.
In terms of education, Mr. Liu holds an MBA from The University of New South Wales and an undergraduate degree from Macquarie University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-07-2023 | 4 689 648 ( 0.96% ) | 3 M $ | 31-03-2024 |
Actieve functies van Zhen Teng Liu
| Bedrijven | Functie | Begin |
|---|---|---|
| SHANDONG LUOXIN PHARMACY GROUP CO LTD | Chief Executive Officer | 31-01-2023 |
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Chief Executive Officer | 23-04-2023 |
Opleiding van Zhen Teng Liu
| The University of New South Wales | Masters Business Admin |
| Macquarie University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on May 05, 1998 and is headquartered in Linyi, China. | Health Technology |
